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WHO WILL LEAD SCIENCE?

"Science is driven by creative individuals.
Given room and scope, scientists develop new
ways of_thinking, new methods and
new approaches· to attacking problems. "
Nobel laureate Torsten Wiesel, M.D.
President Emeritus, Ro�kefeller University
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Making discoveries that transform science
Excerpts from a discussion
about the value of creativity
and risk taking in science.
WHAT FACTORS PROMOTE KNOWLEDGE?

A conversation among
ACTOR AND SCIENCE ENTHUSIAST
Alan Alda
NOBEL LAUREATES
Giinter Blobel
Paul Greengard
Torsten Wiesel
ACTING PRESIDENT
Thomas P Sakmar

WHAT FACTORS PROMOTE KNOWLEDGE?

Alan Alda

Gunter Blobel

The discussion begins with actor Alan
Alda engaging the Rockefeller scientists
in a conversation about the value of basic
science, and the role of creativity and risk
taking in research discoveries.

Science is driven by creative individuals
who are given room and scope to develop
new ways of thinking, new methods, new
ways of approaching problems, and to take
risks to create new kn<?wledge.

Torsten Wiesel (TW): Most of the
money spent since the 1970s as a
result of President Nixon's "war on
cancer " went into basic molecular
biology and genetics, which laid the
groundwork for the developments
we are going to see in the next few
decades.

Tom Sakmar (TS):And let's not forget that
knowledge is the goal of science, and that
information isn't always translated directly
into knowledge. Sequencing the human
genome was a great advance, but putting that
sequence information to practical use
requires a much more detailed understanding
of basic mechanisms than we now have.

Alan Alda (AA):Although the
goal was to cure cancer, research
money went into pure science,
which is undirected and goes wher
ever it's led?

Gunter Blobel (GB): For example, it's
shocking how little we know about how a
cell works, even a primitive bacterial cell.And
that will take a long, long time to figu re out.

TW: It's not that it went undirect
ed.The way science works, you can't
direct it too much because scientists
must be free. But the goal of trying to
understand the basic mechanisms cell differentiation, cell growth and
how cells become cancerous - is
very basic.And that was addressed in
the years after the "war on cancer."

Paul Greengard

AA: What factors promote new
knowledge?

Thomas P Sakmar

Torsten Wiesel
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TW:The best of science has
always been creative, a reason why art
and science belong together.They are
not9-to-5 jobs, in which you have
certain things you do and then you
go home and think about something
else.You always think about what you
are doing in science.Work is part of
you when yo1; are a scientist, as it is
for you, Alan, as an actor.

TS: So you can assemble groups of people
like the Human Genome Project did and
have large collaborative projects to accumulate
information, but innovation and creativity
come from the initiative of individual
scientists.
Paul Greengard (PG):The research of90
percent of scientists recognized by a Nobel
Prize went against the current thinking. If it
hadn't, it wouldn't have been novel, and it
wouldn't have made a major contribution.
AA: How do you know you're not wast
ing your time?
PG: Most scientists who contributed cre
ative ideas didn't have any doubts and were
happy that so many other scientists didn't
think they were right, because this gave them
time to develop and test their ideas.While you
feel bad when researchers say nasty things
about you after you give a speech, it doesn't
affect your conviction that you're right.

DISCUSSION PANEL

GB: In my own research, it was nice to
realize that others thought I was wrong
(laughter) because it left me time to work it
out myself.
AA: When did you know you were right?
TW: It's very intuitive, actually.
GB:You have to do a few experiments to
test your idea.You also have to have the ability
to let your idea die if there is the slightest evi
dence that it is not supported by experiments.
AA: How do you make sense of the
human genome data?
GB:We need the help of physicists and
mathematicians to mine the vast amount of
sequence data of the human genome. For
example, Rockefeller University physicist Eric
Siggia looks for sequence elements that might
be involved in the regulation of transcription.
AA:Which research field is becoming
exciting?
TW: Stem cell research is certainly one
area in which a lot of progress should occur
in the next decade.
GB:We will have to understand how to
make from these stem cells the heart cells or
cartilage cells or whatever other cells we want
to replace in patients. It may take an entire
generation of scientists before we can do this.
AA:Will scientists answer these questions
with new tools and new ways of calculating?
PG:The tools today are enormously more
powerful than they were 10 years ago.
Rockefeller has made tremendous contribu
tions in methodologies - in electron
microscopy, for example.This drives the
research.There's an old German saying: "Die
Methode ist alles," or "methods, tools are
everything." Incredible 1discoveries are going
to be made just by this knocking out and
removing one gene after another and finding
out what they do.
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TW: Industry is moving
very powerfully, interacting
with academic research. For
example, genome sequencing
became an industrial project,
and now proteomics is, with
the sequencing and description
of proteins. Industry is going to
dominate there.
AA: Gunter, why are you
shaking your head at that?
GB: Proteins are not as sim
ple as DNA. Proteins are very
complicated in their interac
tions and how they are organ
izing each other in the cell.
Companies will be able to do
some proteomics, but will
never do the more exciting
things like what Rod
MacKinnon, a scientist at
Rockefeller, has achieved in
solving the atomic structures of
two very important ion chan
nels (see page 8).
AA:When he won the
Nobel Prize, Gunter talked
about proteins that carry signals
that act like ZIP Codes in a
cell. That sounded to me like a
laudable, deliberate effort to
make clear the research.

Alan Alda
Best knownfor his role in the
popularTV series "M'YJ.*S*H ,"
he portrayed Nobel laureate and
physicist Richard Feynman in
the play "QED." A regular
reader ef scientific journals, he
interviews researchersfor theTV
program "Scientific American
Frontiers."
Gunter Blobel, M.D., Ph.D.
Head of Laboratory of Cell
Biology
John D. RockefellerJr. Professor;
Investigator, Howard Hughes
Medical Institute (HHMI)
Nobel Prize in Physiology
or Medicine, 1999
Paul Greengard, Ph.D.
Head of Laboratory of
Molecular and Cellular
Neuroscience
Vincent Astor Prefessor
Nobel Prize in Physiology
or Medicine, 2000
Thomas P. Sakmar, M.D.
Acting President
Head of Laboratory of
Molecular Biology and
Biochemistry
Richard M. and Isabel P.
Furlaud Prefessor; Associate
Investigator, HHMI
Torsten Wiesel, M.D.
President Emeritus
Vincent and Brooke Astor
Prefessor Emeritus
Nobel Prize in Physiology
or Medicine, 1981

GB: I don't think there is any concept
that you can't make understandable to the
educated lay public. I always tell my students
and postdocs - if you can't explain to your
grandmother what you are doing, probably
you don't understand it yourself properly.
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TS:The issue of educating young students
is extremely important. They have to have a
level of understanding of how things have
progressed and how things were 20 years ago
compared to now, and some perspective that
knowledge is not static. In public lectures, I
put_ my own personal history
in context - what I was
"Science is the art of
taught in high school, and
the soluble, as Peter
what I' m learning now.
Medawar told us. You
How
so many fields that I
make hypotheses that
now
use
routinely in my
are testable and that
own work didn't exist 25
can be disproven.
years ago. Science is progres
It is difficult to pre
sive; knowledge is passed
dict what will happen
in the next 20 or 30
from generation to genera
years. There could be
tion.

revolutionary develop
ments that will cat
alyze quantum leaps
and provide informa
tion that we could not
even dream ef now."
Gunter Blobel

AA: Is the future of sci
ence going to be brighter if
there is this excommunica
tion between conservative
and traditional-thinking sci
entists and people who are
probing into the dark
unknown?

PG: No, because science
selects for certain personalities - people
who want to find truth. If the researcher
with the crazy idea seems very smart, the
typical approach is "let him or her have a
shot at it."
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AA:And yet there are these revolutions in
the way we view reality. That's true in acting
as well. When Brando came in, actors who
had thought that they were realistic suddenly
realized that they were very stagey. Brando
helped introduce a new version of reality.
GB:This happened at Rockefeller with
Oswald Avery, who discovered in 1944 that
DNA carried genetic material. But many
scientists opposed this. Avery died before his
research was recognized as one of the most
monumental discoveries of the last century.
PG: If another scientist comes along with
a new way of thinking, and says that your
way is all wrong, and "this is the way it
works," it's very upsetting intellectually. So
there is a tendency, an emotional response, to
resist those new ideas. It's not an admirable
response, but that's the reality of being
human.
AA:An outsider expects science not to
squabble about protecting territory or intu
itions.
TW: Scientists are people. Time is your
best friend, because if you do good work,
even if it's opposed by other scientists, with
time it's going to be recognized.
AA:What if the territory changes? How
does a research institute deal with a "hot"
new area that demands rethinking an old
question or an entire field?

"Scientific knowledge advances
when scientists have concentrated
time tofocus on their research.
It took me three years of investigation to report any results.
GB: Rockefeller doesn't have departments. If
a scientist who heads a lab retires, we don't have
to continue the lab like most universities con
tinue a department.We can create new laborato
ries to rapidly address the next questions
because we don't have to deal with the burden
and boundaries of departments. That's unique to
Rockefeller.

That wouldn't be possible in
most universities."
Bruce Merrifield, Ph.D.
John D. Rockefeller Jr. Professor Emeritus
Nobel Prize in Physiology or Medicine, 1984

AA: A very creative way to organize.
Did the Nobel Prize that you each received
help your field of science in any way?
PG: It helps the people in the field feel good
because the entire field is recognized.
AA: With all that you know about the brain,
do you sense that computing will ever approach
what the human brain can do?
PG: Oh, much more. The interesting ques
tion to me is whether computers will do cre
ative things in the way we do..
AA: What's the thing about wanting to get
there first?
TW: It's a matter of seeing for the first time
something that nobody knew before and you
didn't either. That's a powerful imprinting thing,
and with a few conditioning events you are
hooked for good to search for new discoveries.
AA: I' m very grateful to have been asked to
come talk with you folks, because it's been a
delightful afternoon for me.
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The art of the soluble
Rockefeller University empowers its
stellar faculty with the time, freedom
and resources to follow the science
wherever it takes them. Where is it
taking them?
The following pages spotlight
pathbreaking research of a few of the
university's 75 major laboratories.
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RODERICK MACKINNON
John D. RockefellerJr. Professor, HHMI investigator

Seeing proteins' beauty
and function in their f orn1
"Imagine you want to wiggle your finger,"
says Roderick MacKinnon, M.D., slowly
moving a finger of his right hand to illustrate
his explanation about the importance of ion
channels in body cells.
"Electrical signals, little impulses, go all
the way from your brain down the long
extended nerve fibers to induce the contrac
tion of the muscles in your finger.
"The same sorts of electrical signals allow
me to move and breathe, my heart to beat and
for all of us to have all the thoughts that we
have," he continues. "Those impulses come
from ions moving across the cell membrane."
Because so many life-sustaining functions
begin with ions crossing membranes of cells,
MacKinnon conducts his research there too.
He has solved the structure of the potassium
ion channel and a chloride ion channel.
Without detailed images of these channels,
researchers cannot begin to understand how
even the transmission of nerve impulses
actually works, and how it malfunctions,
contributing to health disorders and drug
side effects.
When MacKinnon decided to "solve " the
structure of the potassium ion channel, some
scientists cautioned him to reconsider.After
all, many others had spent years and had failed
to visualize this specialized protein, a gate
keeper as well as a gateway for potassium ions.
Ignoring the skeptics, MacKinnon perse
vered - and succeeded in solving the struc
ture of the potassium ion channel in 1998,
only two years after joining T he Rockefeller
University.
When MacKinnon and his colleagues
reported this research in Science, its editors
illustrated the cover of that issue with a
three-dimensional, high-resolution image of
the potassium channel. Science later declared
the study one of the year's "breakthroughs."
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Subsequent research revealed the channel's
inner characteristics, homing in on viewing
the atomic-scale parts of the channel and
understanding better how the structure forms
mechanistic features: il). effect, learning how
function and form are intertwined in the
channel's design.
In 2002, in a remarkable follow-up to
their.potassium ion channel research, and this
time featured on the cover of Nature,
MacKinnon and his colleagues published the
structure of yet another channel - a chlo
ride channel. A distinctive hourglass shape,
seen for the first time in MacKinnon and
colleagues' research, defines the chloride
channel, and provides a striking contrast to
the pyramid-shaped cavity of the potassium
ion channel.
To visualize the structures of these ion
channels, MacKinnon's lab uses X-ray crys
tallography, a multi-step process resulting in a
diffraction pattern from a crystal, which is
then rendered as a three-dimensional pic
ture. The result offers literally an atom-for
atom image of the ion channels in question
- a view of a beautiful evolutionary solu
tion to the problem of moving things across
solid membranes.
That nature could come up with some
thing so ingenious is one of the breathtaking
marvels of basic research, and exemplifies
why MacKinnon and many of his colleagues
and students at Rockefeller undertake their
work- for the sheer joy of discovery.
When then President Torsten Wiesel,
M.D., asked him to join the university's fac
ulty, MacKinnon says, "Rockefeller told me,
in essence, that they like scientists who take
risks and they were willing to take me on in
that attempt. It is rare that an institution can
offer that kind of support."

A protein has a sophisticated architectural plan cre
ated by nature. Solving protein structures - visu
alizing their shapes - is an ongoing, and impor
tant, activity of basic science researchers.
In addition to their canny beauty, protein struc
tures provide us with an understanding of the
process of life. Each proteins shape corresponds
with its function, whether it is to "shake hands"
with other proteins, or to serve as a passage for
small molecules in the body movingfrom one place
to another. Pictured here, the structure of a chloride
ion channel, a specialized protein, shows that it
permits two streams of chloride ions (shown in red)
toflow through its center, moving tens of thou- sands of ions per second from one side of a cell wall
to the other.
For an interactive illustration of an ion channel,
visit www.rockefeller.edu/ discovery.
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MARIA KARAYIORGOU

Genetic clues to schizophrenia

I.
Maria Karayiorgou, M.D. , heads one of the
few laboratories in the world that searches
for the genetic causes of schizophrenia by
looking at people with the disease before
studying lab animals.
"It's the other w�y around in most labs,"
says Karayiorgou, head of The Rockefeller
University's Laboratory of Human
Neurogenetics."All of our hypotheses and
studies begin with human patients."
Her unique approach has led to the iden
tification of several genetic mutations that
may underlie schizophrenia - as well as to
possible clues about how to better diagnose
and treat this disease.
Affiicting two million Americans, schizo
phrenia is characterized by disordered think
ing and deficits in emotional and social
behavior. Like heart disease and diabetes, it is

The chart above is one of the research tools that
help Maria Karayi01gou study the inheritance of
genes that confer susceptibility to schizophrenia.
Charts - also called pedigrees - show family
members' relationships to each other. This pedigree
links together 2 7 schizophrenic patientsfrom the
Micronesian island of Kosrae.

IO

triggered by multiple genes whose activity
patterns in specific body cells change, often
in reaction to one or more unknown envi
ronmental influences.
Before Karayiorgou joined Rockefeller in
1996, her search for the identity of these genes
led her to a small region of human chromo
some 22.This particular patch of DNA, she
discovered, was lacking, or"microdeleted," in
peopie with schizophrenia: of the 100 unrelat
ed people with the disease whom she studied,
all possessed these microdeletions, while all
200 healthy"control" subjects did not.
At Rockefeller, she and other researchers
created the first animal model of schizophre
nia by deleting or "knocking out" a gene
, called PRODH. It codes for an enzyme that
regulates levels of the amino acid praline, a
crucial brain chemical required for proper
functioning of neurons. Mice lacking this
gene possess a hallmark of human schizo
phrenia: inability to filter the multitude of
sensory inputs, such as sounds, to focus on
only one stimulus at a time.
Karayiorgou continues to explore chro
mosome 22. Recently she and collaborators
published a systematic study using DNA
from three independent populations: chil
dren with childhood-onset schizophrenia,
and adult North Americans and South
African Afrikaners with schizophrenia. Of
the 13 genes studied, two conferred suscepti
bility to schizophrenia - one of which
turned out to be PRODH.
"This was an interes_ting finding because
the particular pathway in which PRODH is
involved is largely undescribed," says
Karayiorgou."It is a novel pathway that will
open up several different avenues for new drug
development."

Through this pedigree, Maria
Karayiorgou s research team
traced to one person - or
founder - seven of the 5 6
South African Afrikaner
families whom the scientists
are studying as part of their
research on the genetics of
schizophrenia.

_\\'c the_refore have shown
tha1 genealo�ca! research, the
!J?pulaoon, allhoug h tedious and laoor-iniensive, is f�bl ·,
_
earuJ�
aidourgcneoc rud1es.

CO\'.CLL' IONS
tbal Ille
Taken together, results from our thret studies sugg� io, a
standards des1
Afrikaner population conforms lo the scans that ' plo1�1 LD to
geoo me-11ide _
'.
. ulation appropriate for
disorde�, such as sch1zophrenl3.
�:p common, multigenic
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Deceased Male
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Filled symbol shows afamily member
affected by schizophrenia.
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ELAINE FUCHS
HHMI investigator

Skin and hair:
Means to a genetic end
Skin and hair proteins fascinate Elaine Fuchs,
Ph.D., who heads the university's Laboratory
ofMammalian Cell Biology and Development.
From proteins that act like glue to hold
together skin to those that form a tough
outer barrier to keep harmful pathogens out
and essential fluids in the body, Fuchs's
research goal is the same: understand how
skin proteins function at the level ofthe cell.
While unraveling the secrets ofour body's
largest organ, she finds clues to the genetic
origins ofskin diseases, including cancer.
Fuchs is addressing one oftoday's crucial
biological questions: "What are the amazing
properties ofstem cells ofthe body that enable
them to develop into tissues and organs?"
Her lab studies how skin stem cells are
able to divide and churn out skin cells in a
Petri dish, a process used to treat burn vic
tims. "Ifwe understand enough about the
biology ofskin stem cells, and how they can
make both hair and skin, will we be able in
the future to coax stem cells ofthe skin or
hair into becoming something that they nor
mally would not become, such as a blood
vessel to the heart, neurons for the brain, or
pancreatic islet cells?" she asks.
These tissues can be severely damaged by,
respectively, heart attack,Alzheimer's and
diabetes. Ifskin stem cells can be persuaded
to become other tissues, they could be the
basis for new treatments.
Scientists must first thoroughly under
stand normal stem cells. "There is much
promise for stem cells in revolutionizing
medicine, but there is so much we must first
learn about stem cells before we can reach
the stage ofeven knowing whether this
might be possible," she points out.
Unlike other stem cells, skin stem cells
can be cultured easily in the lab. With these
lab cultures, Fuchs and her research team
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study stem cells and learn about how they
choose between making skin epidermis or
making hair. Employing modern molecular
biology techniques, the scientists trick stem
cells into making one choice - for example,
to become hair. The se1entists test their find
ings by introducing small mutations in spe
cific skin genes in laboratory mice. More
often than not, this key step has guided them
,
to the genetic bases ofhuman skin disorders.
Fuchs's lab has determined the genetic
basis ofa type ofskin tumor that affects the
scalp.The lab hopes to understand the genet
ics ofsquamous and basal cell carcinomas,
the most common types ofhuman cancers in
the world. "Because oftheir extraordinary
self-regenerating properties, stem cells, when
gone awry, are the likely cause ofmany ifnot
most types ofhuman cancers," says Fuchs.
While her goal is to unravel the biology
of normal cells, not the causes ofskin dis
eases, Fuchs's results exemplify the unexpect
ed benefits ofbasic research to medicine as
well as science.

Skin cells' durability comesfrom the protein
keratin. This protein also makes up the bulk
of hair cells. To switch on hair keratin genes
and turn cells into keratin factories, hair pre
cursor cells need a signal to tell them to make
a transcriptionfactor between beta-catenin
and a partner protein. The hair follicle at right
is stained with antibodies to reveal the pres
ence of beta-catenin �ime green). In blue are
the cells' nuclei. Beta-catenin normally stays
at the cells' borders, but the hair precursor cells
(at base) have received their signal and begun
to move with their partners to the nucleus.

THE ROCKEFELLER UNIVERSITY
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JAN BRESLOW
Frederick Henry Leonhardt Prefessor

JEFFREY FRIEDMAN
Marilyn M. Simpson Professor, HHMI investigator

MARKUS STOFFEL
Robert and Harriet Heilbrunn Prefessor

"Syndron1e X" genetics on island ofKosrae

The cluster of disorders known as "Syndrome
X" is relatively unfamiliar to the public. It is
not a new disease, but a new name for a col
lection of health problems - obesity, dia
betes, high blood pressure and high blood
cholesterol. Tens of millions of people have
one or more of these four disorders.
Because all four conditions simultaneous
ly can affect the same individual or many
family members, a common set of flawed
genes may trigger the syndrome. To look
for a possible common thread in all four,
and to find the genetic roots of each disease,
Rockefeller University laboratories that
specialize in research on obesity, diabetes,
hypertension and heart disease are jointly
conducting research on Syndrome X.
Their partner is the D epartment of
Health on the Pacific island of Kosrae in
Micronesia, about 5 ,400 miles from Los
Angeles.
The Rockefeller scientists have turned to
this remote population of over 3,000 people
for two reasons. One, most Kosraeans can trace
their heritage to a relatively small "founder"
population of about 50 people who came
from Polynesia about 1,000 years ago. Later, in
the mid- to late-19th century, Caucasian
whalers visited and in many cases settled on
the island, and so today many Kosraeans can
trace their ancestry to both groups.
The second reason the Kosraeans are ideal
for studies of Syndrome X involves the more
recent "westernization" of their lifestyles.
For most of their thousand-year history,
Kosraeans were active.They ate native foods
and were reported to be relatively lean. But
in the years following World War II, most
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began leading a sedentary lifestyle while eat
ing foods with high salt and fat contents.
Subsequently, a disproportionate percentage
of people on the island have developed one
or more conditions associated with
Syndrome X.
By analyzing the genetic inheritance pat
terns of the entire Kosraean population,
Rockefeller scientists Jan Breslow, M.D.,
Jeffr�y Friedman, M.D., Ph.D., and Markus
Stoffel, M. D., Ph.D., hope to solve the ongo
ing mystery of why some people develop
these diseases, while others with the same
lifestyle do not.
They have conducted a comprehensive
epidemiological and genetics study involving
over 90 percent of the adult population or 2,188 men and women - on Kosrae. For
each Syndrome X disorder, Friedman and his
Rockefeller colleagues are scrutinizing DNA
samples provided by volunteers in Kosrae to
identify genes involved in each disease and to
verify previous findings of candidate genes
from their research with lab animal models
or human patients in the United States.
Blood samples were provided willingly,
because Kosraeans want to understand why
they are so vulnerable to the Syndrome X
disorders. "People on the island should bene
fit from this study because they have become
more aware of these health problems,"
explains Friedman, director of the Starr
Center for Human Genetics at Rockefeller.
"This awareness is a starting point for pre
vention as well as treatment."

Heart disease
Jan Breslow

Obesity
Jeffrey Friedman

Diabetes
Markus Stoffel

The island of Kosrae

THE ROCKEFELLER UNIVERSITY
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TERRY GAASTERLAND

Theater of the cell.

I,/
)..l
1/

Genes were biology's command performers
during the last_ decade of the 20th century.
We expected their monologues· to tell us
much about life. Today, genes are but one
class of actors in the theater of the
cell. Other _leading parts go to
proteins and complexes that
become active when
genes, or groups of genes,
tell them ·to do so.
Terry Gaasterland,
Ph.D., has the singular
qualifications to help us
understand these actors'
"motivations," revealing their
mechanisms of communication
and transit within the cell.
Gaasterland's tools for studying genes and
other molecular actors are computers, not
pipettes or Petri dishes.
"I examine data generated by gene
sequencing labs all over the world," says the
head of Rockefeller's Laboratory of
Computational Genomics. "I knit the data
together with gene expression: data and other
sources to form a picture of the biological
systems inherent in all organisms.Whole
genomes, or the maps of all genes for organ
isms like human, fly and mouse, have given
us much more information to work with."

New ways efvisualizing information come with
the new territory ef computational genomics.
Gaasterland devised the above "ball ef yarn''
system that depicts genes' interactions with one
another when they are expressed, or turned on.
Here, several genes in the bacteria Vibrio
cholera interact when substances necessaryfor
the organism5 metabolism are present .All the
points along the circle5 circumference represent
genes.Arrows indicate genes.consistently co
expressed - in this case, during metabolism.

r6

This information helps scientists identify
. families and homologues of proteins and
their structures.
Proteins, molecules scripted and regulated
. by genes, are the essei:ce of cellular life.
They're the workhorses that send and receive
signals, bind with receptors and meet up
with other proteins to play important roles
in t�e hody. Complexes - groups of pro
teins or proteins mixed with other cellular
products - perform jobs only when they
are activated, or turned on.
Why is this important? Major diseases
from cancer to cystic fibrosi� are based on
mistakes in the structure or composition of
oneor more proteins. Ultimately, knowing
more about which genes turn on and off for
which disease, and how the corresponding
proteins (individually or in key groups) mal
function, allows scientists to see the entire
"cast" performing in a disease. This knowl
edge provides the means for designing new
drugs to intervene with the proteins and
recast disease-causing players.
As part of their research, Gaasterland and
her colleagues build software tools to infer
relationships and to model protein systems.
These intricate role-playing exercises help
scientists understand how .disease evolves in
the body.
Because scientific interactions at
· Rockefeller are not restricted by traditional
departme�tal structures, Gaasterland's compu
tational �nsights are quickly transferred to the
university's many biology labs. The fluid
boundaries between disciplines help to clarify
existing biological research and prompt new
measurements to be taken in the laboratory.

A protein� structure often
reveals something about its
role in the body, depending
on the counterparts with
which it peiforms. Terry
Gaasterland compares the
"readout" ef an organism�
gene expression data (back. ground) with protein struc
tures (foreground) to learn
more about proteins'func
tions. Her comparisons often
suggest new experimentsfor
biologists working with tra
ditional tools.

THE ROCKEFELLER UNIVERSITY
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MADHAV DHODAPKAR
Irene Diamond Assistant Prefessor

Tailor-n1aking a cancer vaccine
for people "With n1ultiple n1yelon1a
People with multiple myeloma rarely get
well even after undergoing chemotherapy
and transplants of stem cells from their
own bone marrow. However, a cure to this
pernicious blood cancer is being nurtured
in the "translational" research of Rockefeller
University physician-scientist Madhav
Dhodapkar, M.D.
Like several of the university's scientists,
Dhodapkar traverses the worlds of patient
care and basic research, translating the accom
plishments of each to improve public health.
Dhodapkar's scientific journey begins and
ends with the patient with multiple myeloma,
which develops when immune system cells
go awry.
From his patients with this disease,
Dhodapkar retrieves immune cells, including
one called the dendritic cell.The cells are iso
lated and processed to develop a tumor vac
cine specifically tailor-made for each patient.
Dendritic cells - discovered by Ralph
Steinman, M.D. , who is the Henry G. Kunkel
Professor at Rockefeller and head of the
university's Laboratory of Cellular Physiology
and Immunology - normally call into
action the "killerT cells" of the body's
immune system.To guide killerT cells to
their precise targets - which typically are
bacteria or viruses that have invaded the
body, or cancerous tissue in the body the dendritic cells engulf some of the target.
Dendritic cells then display on their surfaces
various proteins or other substances from
cancers or foreign bodies.
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However, because they often escape the
attention of the dendritic cells, cancers are
not always attacked as they should be by the
powerful killerT cells.
To insure that the dendritic cells recognize
the cancer, Dhodapkar's lab primes a sample
of these cells from a patient with multiple
myeloma.The cells are "treated" with a sub
stan�e known to activate killerT cells. During
carefully monitored clinical research atThe
Rockefeller University Hospital, patients
with multiple myeloma are then injected
with the primed dendritic cells.
If over time it proves safe as well as effec
tive in persuading the killerT cells to recog
nize and destroy multiple myeloma in a large
group of patients, this new experimental
treatment may become a "cancer vaccine."

Cluster containing
dendritic cell and other
immune system cells.

Multiple myeloma cells
in the blood (above) can't
be removed by surgery
the way most tumors in
the body can, and they're
resistant to conventional
chemotherapy and radia
tion. In a novel treat-

ment, Madhav
Dhodapkar amplifies
patients' own immune
cells, including the den
dritic cell (opposite), in
the lab. He then returns
them to the body with a
bonus - an experimental
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cancer drug. Enhancing
the immune cells, and
using them as a delivery
system, forms the basis ef
a potential new treatment
for this and other incur
able cancers.
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MARY E. HATTEN
Frederick P. Rose Prefessor

NATHANIEL HEINTZ
HHMI investigator

Building a genetic atlas of the brain

Two Rockefeller scientists are shooting
time's arrow forward at the rate of about a
decade a month as they"map" the 1,0, 000
genes active in the human brain in record
time.
If not for their novel research method, the
remainder of this century would be needed
to pinpoint when and where in the brain
gene expression, or activation, occurs. The
"bacterial-transgenic" method used by
NathanielHeintz, Ph.D. , and Mary E.
Hatten, Ph.D. , accelerates this goal with
rapid-fire precision.
"We can analyze up to 500 genes per
year, and we've already done so on about
200," saysHeintz."We'll cover all the well
known genes in the first couple of years."
Why create a map of the genes that are
active in the brain? "The actual pattern of
gene expression can give you a first inference
into the function of a gene,"Heintz explains.
When a gene is active, it expresses a signal
- a messenger molecule to specific cells in
the brain. The messenger instructs the cells
to manufacture a specific protein. D epending
on its genetic recipe, that protein can help
form another brain cell or one of the many
chemical substances, or neurotransmitters,
through which brain cells communicate
with each other.
When neurological diseases such as
Alzheimer's occur, one or more proteins are
misshapen, too abundant or insufficient.
Finding and scrutinizing the genes responsi
ble for these protein mistakes provide clues
to the origins - and possible treatment of the disease.
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When their National Institutes ofHealth
supported project is complete, Hatten and
Heintz will deliver to the worldwide scien
tific community a free, unrestricted, compre
hensive database on ge?e expression in the
brain.
ForHatten andHeintz, both neuroscien
tists, their genetic atlas recreates for all scien
tists tp.e experience of sitting down at a
microscope and seeing thousands of cells and
their corresponding structures. The atlas will
benefit neuroscientists in every conceivable
basic and clinical research field, because it
will give unprecedented levels of insight on
neurological development and stroke,
Alzheimer's and Parkinson's disease.
"We know this atlas will be important,"
saysHatten."Our initial work already has
provided us with intriguing new informa
tion about cell migration, the specialized
movement of cells in the brain, that we never
would have found using existing tech
niques."
Hatten andHeintz have named their
ambitious project"GENSAT," for Gene
Expression Nervous System Atlas. This
acronym is meant to invoke LANDSAT, a
satellite system for investigating vast terrain
in close detail.
The difference is thatHatten andHeintz's
research"topography" is the brain.
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In the top right scientific
image, the expression of a
gene called "dopamine
receptor Drdla" is high
lighted in cells in the brain
region called the striatum.
Cells with these corre
sponding receptor proteins,
which were manufactured as
a result ofthe genes activa
tion, projectfibers (see arrows
in large image, above left) to
another area of the brain,
called the substantia nigra
(detail, lower right).
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Since dopamine, a chemi
cal messenger, is deficient in
the brains of people with
Parkinson s disease, under
standing the genetics of the
dopamine-producing system
of the brain improves under
standing about the origins of
this neurological disorder.
Mapping the expression, or
activity pattern of a single
gene, such as Drdla, over
time reveals the cells associ
ated with that gene and the
other cells in the brain with
which they interact.
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TOM MUIR

Creating "n1olecular Legos® " by
snapping together natural and synthetic n1olecules
Tom Muir, Ph.D. , brings a different set of
tools to the study of biology- those of
organic chemistry.
While organic chemists manipulate mol
ecules to create a test tube full of a desired
compound, Muir goes one step further: his
creations are designed to study precise bio
logical problems in the test tube and the cell.
"Not only can we use these sophisticated
approaches to manipulate the structure and
function of genes and proteins in the test
tube, but we can increasingly do this in liv
ing cells or whole animals," says Muir, who
heads the Selma and Lawrence Ruben
Laboratory of Synthetic Protein Chemistry.
Called "chemical biology," this emerging
field allows Muir and other scientists to rap
idly ascertain functional information about
key biological molecules, including those
involved in cancer, Alzheimer's disease and
other disorders, and to create systematically
novel drugs for the possible treatment of
these diseases.
One of the new relatively easy-to-use
tools that has emerged from Muir's lab stacks
together chunks of proteins in a technique
called "expressed protein ligation."
This novel approach- available to all
scientists, not just those at The Rockefeller
University- provides for the first time a
technique to synthesize a full-sized protein,
an important tool in understanding any
protein's overall function in a cell.
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Recently Muir's lab has applied similar
protein-linking technology to study protein
folding. Newly made proteins- which
typically adopt a linear topology, or form,
with dangling ends lik� those of a string cannot function properly until they fold
into the correct three-dimensional shape.
Indeed, misfolded proteins are associated
with Alzheimer's, cystic fibrosis and "mad
cow" disease.
But some proteins adopt a circular
topology, leading Muir to ask what effect
such an altered form might have on protein
folding. Like a true chemist, Muir tackled
the problem by artificially linking the two
free ends of a protein together into a circle,
then observed it fold. He found that the
new molecule folded into the same shape as
its natural linear form, but more intriguing,
it did so more quickly.
"This suggests that topology plays a very
important role in protein folding, which is
an emerging theme in the protein folding
field," says Muir.
Muir's overriding goal, however, is to
develop chemical tools that any researcher
can use. "After all," he asks, "what good are
the tools if only a few people can use them?"
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Translating research into hun1an health
"I like donating my cells to science," explains Susan, a clinical study volunteer
at The Maurice R. and Corinne P Greenberg Hospital of The Rockefeller
University.
The first in the nation dedicated to clinical research, the 92 ::- year-old hospital
serves as a bridge connecting the university's basic research labs to the world of
human health, to people with diseases. People like Susan.
Susan is afflicted with a common autoimmune disorder. Rockefeller
physician-scientists' studies of the disease in Susan inspire the direction of
many laboratory investigations, and help translate hard-won lab discover ies
into potential health care and biomedical research achievements.
The hospital, where paintings by Frank Stella and other renowned artists
hang in the hallways and patient rooms, bustles on most days with the activity
of physician-scientists, nurses and other health care professionals, and M.D.
Ph.D. students in the top-rated joint program Rockefeller offers with Weill
Medical College of Cornell University and Memorial Sloan-Kettering
Cancer Center.
On any day, the most important people there are the study participants, all of
whom are involved in approved clinical research protocols.
"The patients' altruism is vital to medical progress," says Barry Coller, M.D.,
D avid Rockefeller Professor and the hospital's physician-in-chief. "We owe
them a great debt and must make their safety our highest pr ior ity. Ever yone at
Rockefeller views this commitment as a sacred trust."
Susan concurs: "I would not volunteer if Rockefeller was not such a
supportive environment.The hospital cares for the total person - clinically,
mentally and emotionally."
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When overweight lab mice or
humans lose weight due to
dieting, their bodies' metabo
lism changes. Diet-induced
weight loss results in a decline
in blood levels of leptin, the
protein byproduct of the
"obese" (or "ob") gene dis
covered by Jeffrey Friedman,
M.D., Ph.D., at The
Rockefeller University.

What other metabolic
Zolotov, M. D. (right), are
changes occur in diet-induced
evaluating the effects of leptin
weight loss? Will leptin treat treatment on overweight
ments keep the hormone at
women on a low-calorie,
healthy diet. This project, one
normal levels in the dieters'
of the "translational research"
bodies and help accelerate
weight loss, or lessen some of
programs at The Rockefeller
the unwanted effects of a low University Hospital (above),
calorie diet?
is the most comprehensive
Since low leptin levels may study ever conducted on the
be a potent stimulus to weight metabolic changes that occur
gain, Friedman and Sagit
in dieting.
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Hepatitis C research:
Whatever it takes
The body's immune system holds the key to
eliminating hepatitis C, the source of a hidden
epidemic in the U.S. Locating that key depends
on scientists' learning why many people's
immune systems fail to mount an effective
response to hepatitis C, while others' rise to the
viral challenge.
Charles Rice, Ph.D., director of the
Center for the Study of Hepatitis C at the
university, aims to do "whatever it takes " to
combat this illness because of its devastating
toll on the people of NewYork City and
around the world.
Only a quarter of the four million people
in the United States infected with hepatitis C
know they have the virus. The life-threaten
ing liver disease that occurs with infection
takes decades to develop, and for those in the
final stage of disease, liver transplant remains
the only treatment. If more people with the
virus were tested and sought treatment, scien
tists could better understand the immune sys
tem's interaction with the virus. Creating a
metropolitan center for clinical and basic
research advances the research - and aids
more patients.
In the three years that Rice has headed the
new center, the basic research has blossomed.
"Immunologists are having a heyday now,"
says Rice. "We know that the immune
response in individuals chronically infected
with hepatitis C has a strong antibody com
ponent, but a very weak cellular component."
Figuring out how to boost the cellular com
ponent could be an important part of future
therapy or vaccination.
The center's basic research focuses inten
sively on the immune system's white blood
cells (T and B cells) that attack and destroy
invading microbes.
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"More people than we thought clear the
virus from their system, and we need to
understand how they do this," adds Rice.
"Having the center's home base in NewYork
City serves the research well: we have a large
pool of people receivfng clinical care for
hepatitis C, as well as a clinically challenging
sub-group also infected with HIV But we'd
like ,to treat, and study, more people."
A new clinical research component of the
center supports pediatric sufferers of hepatitis
C. "We need to know more about when and
how to treat children," says Margaret R.
MacD onald, M.D., Ph.D., co-founder of the
Center for the Assessment and Treatment of
Children Infected with Hepatitis C.
W hile hepatitis C immunology is yielding
clues about the disease, other areas demand
intense research attention. "We really need to
get the virus's replication cycle going in cell
culture," says Rice. "With this next phase of
the research worked out, we'll be able to
examine many aspects of the virus that we
can't understand right now and open new
avenues for drug development."
Rice's record demonstrates that he gets
results. In 1997, before joining Rockefeller,
he led the team that made the first infectious
clone for the virus, demonstrating that the hep
atitis C virus alone - not one of its brother or
sister hepatitis viruses - is sufficient to cause
the disease. In 1999, he and his colleagues dis
covered mutations in the virus that allow it to
replicate its genome in cell culture - another
milestone in research on the disease.

Charles Rice (right), Maurice R. and
Corinne P Greenberg Professor and director
of the Center for the Study of Hepatitis C,
and postdoctoralfellow A rash Grakoui study
the entire life cycle of the hepatitis C virus.
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RESEARCHERS IN TRAINING

Learning science
by doing science
"At Rockefeller, nobody boxes you in as a scientist," says fourth-year graduate
student Tshaka Cunningham, describing the university's uniquely unstructured,
highly successful training of students to become leaders and innovators in bio
medical science.
Cunningham, recipient of the university's prestigious David Rockefeller
Fellowship in 2002, is learning by "doing sciente " in one of the world's top
AIDS research labs: the Aaron Diamond AIDS Research Center, directed by
David Ho, M.D., Irene Diamond Professor at The Rockefeller University.
Students at Rockefeller quickly get into the nuts and bolts of conducting
scientific research because coursework is minimal, unlike most other graduate
training programs in the life sciences. At Rockefeller, graduate training often is
described as an "apprenticeship with a master scientist."
From the master scientist, or mentor, as well as the other researchers in the
lab, the student learns a framework for asking the crucial scientific question,
designing an experiment to answer the question and interpreting the results.
Cunningham, an apprentice with Mark Muesing, Ph.D., is training for a
scientific career in HIV/ AIDS research.With his colleagues, Cunningham has
identified a possible platform for gene-therapy-based vaccines
"As a Rockefeller graduate student, my mind moves quickly and my hands
keep pace in the lab," says the Princeton University graduate. "What's my incen
tive? In my area of research on HIV/ AIDS, 40 million people will potentially
benefit if we make a major breakthrough."
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Macrophages with
noninfectious HIV
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INTERDISCIPLINARY RESEARCHERS IN TRAINING

The laws of living n1atter

For mathematicians or physicists seeking
potential biomedical applications of their
highly specialized training, 21st-century
"biology provides almost an embarrassment
of riches," says Erik van Nimwegen, Ph.D.,
a postdoct�ral fellow at the Center for
Studies in Physics and Biology.
Biology is "like another civilization; the
whole way of thinking is very different from
physics," adds Tsvi Tlusty, Ph.D., another fel
low at the center, presciently established in
1994 atThe Rockefeller University.
These and other young physicists and
mathematicians study the civilization of
biology as part of the university's plan to
build more bridges, and more opportunities
for collaboration, between the disciplines.
While biologists eagerly clear space at
their lab benches - and computers - for
mathematicians and computer scientists to
help organize and analyze the complex data
of the DNA code and the proteins that
genes determine, physicists open new
avenues for understanding "living matter."
Studying how a cell behaves, for example,
reveals as much as knowing what it con
tains. Biology depends more and more on
physicists to explain symmetry and change,
or stability and instability within living
organisms down to single molecules.

Silk and soap settle a
century-old flap, and
encourage physicists to
study turbulence in living
organisms.
Here the movements
of a silk filament in liq
uid soap, research by
Rockefeller scientist
Albert Libchaber in col
laboration with several
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colleagues, reveal the
dynamics of how .flexible
objects move in fluid
forces. The group of scien
tists discovered that, tech
nically, a flag could fly
straight rather than con
stantlyflap, given the
right conditions. This also
applies to understanding
how fish swim in water.

One of the center's scientific leaders,
Albert Libchaber, Ph.D., the university's
Detlev W Bronk Professor, trained in
condensed matter physics and pioneered
the field of complexity theory. Libchaber
views biology as a model frontier that
will help establish new physics and
mathematics.
Where some may see physics and
mathematical contributions as a form of
applied science, Libchaber and his
colleagues take an inverse view. Biology
offers a universe as vast as the Milky Way,
revealing laws undiscovered in other
natural systems.
Several years ago, Libchaber began a
project to learn more about fluid dynam
ics.To create a simple version of a "fish
swimming" phenomenon, Libchaber,
along with his Rockefeller students and
postdocs and his colleagues at New York
University's Courant Institute of
Mathematical Sciences, studied silk
filaments in soap film, revealing the four
main conditions of an object moving in
water or air.
The resulting publication in Nature
revealed for the first time how flags flap
in the wind. The findings served as a
starting point for a more elaborate project
studying tigerfish as they move through
water. Information about the turbulence
effects of the aquatic animals' movements
may become the cornerstone of new
developments in physics.

Using a similar approach, Libchaber
and his lab members study DNA, but not
for its biological functions.They study the
physics of DNA - how it is structured,
broken down and reassembled during
replication - to theorize new means of
computing. DNA provides a more
complex set of information-processing
methods than any computer, ever con
ceived by humans.
As well as new theories, new tools
emerge from the interface between
physics and biology. For several years,
Benoit Dubertret, Ph.D., a postdoctoral
fellow who works with Libchaber, has
been searching for b!ological applica
tions of quantum dots - crystals of only
a few hundred atoms that are visible with
a single wavelength of light.
With another Rockefeller scientist, Ali
H. Brivanlou, Ph.D., head of the
Laboratory of Molecular Vertebrate
Embryology, Dubertret has succeeded in
applying quantum dots to illuminate how
embryonic frogs develop into a whole
orgarusm.
Could quantum dots also illuminate a
healthy human cell's change to malignan
cy? Only a physicist working with a biol
ogist may ever answer the question.
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Using molecular beacons, Noel
Goddard (above left) studies
rigidity of single-strand DNA.
As a graduate student in the
Laboratory of Experimental
Condensed Matter Physics, she
combines her formal training in
physics with an apprenticeship
in molecular biology mentored
by laboratory head Albert
Libchaber (above).
The university's graduate
program is "very effective," says
Nobel laureate and former
Rockefeller President Torsten
Wiesel, M. D. "A student
spends time in a lab and learns
from and interacts with a master
scientist."
Rockefeller University has
many educational partners,
including Weill Medical College
of Cornell University and
Memorial Sloan-Kettering
Cancer Center. With them, it
offers a highly rated M. D. Ph.D. program to train physi
cian-scientists for the future.
Through New York University's
Courant Institute of
Mathematical Sciences,
Rockefeller offers students curric
ula linking the disciplines of
biology, physics, mathematics and
computation, providing young
scientists with tools to under
stand the patterns of life.
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Selected prizes and awards
2001-2002
BRIAN T. CHAIT
Frank H. Field and Joe
L. Franklin Award for
Outstanding Achievement
in Mass Spectrometry
(American Chemical Society)
Academy Fellow, NewYork
Academy of Sciences
JOEL E. COHEN
Mayor's Award for Excellence
in Science and Technology
BARRY S. COLLER
Warren Albert Foundation
Award
JAMES E. DARNELL JR.
Albert Lasker Award for
Special Achievement in
Medical Science
Academy Medal for
Distinguished Contributions
in Biomedical Science
(New York Academy of
Sciences)

HIRONORI FUNABIKI
Searle Scholar Award
CHARLES GILBERT
Fellow, American Academy
of Arts and Sciences
PAUL GREENGARD
NARSAD Julius Axelrod
Neuroscience Award
(shared with Eric Kandel and
Arvid Emil Carlsson)'
A. JAMES HUDSPETH
Fellow, American Academy
of Arts and Sciences
JOSHUA LEDERBERG
Benjamin Franklin Medal for
Distinguished Achievement
in the Sciences
(American Philosophical
Society)
BINGWEI LU
Arnold and Mabel
Beckman Award
Alfred P. Sloan
Research Fellow

TITIA DE LANGE
Paul Marks Award for
Cancer Research

RODERICK MACKINNON
Gairdner Foundation
International Award

MADHAV DHODAPKAR
NewYork Community
Trust Scholar
Damon Runyon-Eli Lilly
Clinical Investigator Award
JEFFREY M. FRIEDMAN
Bristol-Myers Squibb
Award for Distinguished
Achievement in Metabolic
Research

BRUCE S. MCEWEN
Edward J. Sachar Award
(Department of Psychiatry,
Columbia University College
of Physicians and Surgeons)
JOHN MCKINNEY
Ellison Medical Foundation
New Scholar Award in
Global Infectious Disease

Leslie B. Vosshall, Ph.D. (right), and Mike
Rout, Ph.D., are the most recent offive
Rockefeller scientists to have been honored
with the PECASE (Presidential Early
Career Awardfor Scientists and Engineers)
since the award was established in 1996.

FERNANDO NOTTEBOHM
Ellison Senior Scholar
Award in Aging
F. NINA PAPAVASILIOU
NewYork Community
Trust Scholar
ROBERT G. ROEDER
Dickson Prize in Medicine
(University of Pittsburgh)
MICHAEL P. ROUT
Presidential Early Career
Award for Scientists and
Engineers
SHAI SHAHAM
Sidney Kimmel Cancer
Scholar Award
EREC STEBBINS
Burroughs Wellcome
Fund Investigator Award
in Pathogenesis of
Infectious Disease
RALPH M. STEINMAN
Member, Institute of
Medicine
MARKUS STOFFEL
Bristol-Myers Squibb
Unrestricted Grant Award
for Metabolic Diseases
LESLIE B. VOSSHALL
Presidential Early Career
Award for Scientists and
Engineers

In laboratory cultures of
human and rodent brain tis
sue) Nobel laureate Paul
Greengard) Ph.D. (left) and
his Rockefeller University
colleagues showed that the
hormone estrogen prevents
the accumulation of "senile
plaques that build up in
the brains of most people
with the devastating disease
Alzheimer's.
Above is a neuron) the
most common type of brain
cell in humans and most
animals. This image of a rat
neuron was stained to iden
tify the locations of proteins
forming the "senile
plaques.
The plaquejorming pro
teins are located primarily in
a part of the neuron called
the Golgi compartment
(bright area of image) - a
part of the cell responsible for
manufacturing) warehousing
and shipping certain cellular
products. Greengard found
that estrogen scoots the
plaquejorming proteins out
of the Golgi compartment.
Scientists hypothesize that
the longer these proteins stay
in the Golgi network) the
more likely they may be to
develop into the beta amy
loid of "senile plaques. n
J

JJ

JJ
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Fron1 DNA to a postgenon1ic world:_
Discoveries that (continue to) transforn1 science
W ith the 50th anniversary of the discovery of
DNA's double-helix structure by James Watson and
Francis Crick at Cambridge University upon us,
the world of science eagerly anticipates a season of
celebratory conferences and honors marking the
occasion. Rockefeller University will join the fes
tivities, to honor its own chapter in the textbook of
DNA history.
In 1944, Rockefeller scientists Oswald Avery,
Colin MacLeod and Maclyn McCarty showed for
the first time that DNA is the chemical substance
of heredity. This crucial finding set the stage for
Watson and Crick's unveiling the physical structure
of this double-stranded molecule nine years later.
Half a century later, DNA has become a cultural
phenomenon in its own right, with ripple effects

Florence Sabin, renowned
anatomist and histologist
becomes first female
member of Institute,
equivalent to
full professor.
1925
June 14. 1901
Rockefeller Institute for Medical
Research incorporated

1901

1905

Rockefeller researchers
collaborate with New
York City Board of
Health to reduce bacte
ria in city's milk supply.
1902

Peyton Rous discovers virus
can cause cancer. 1911

1910

1915

1920

1925
Donald van Slyke
perfects appara
tus to analyze
blood gases.
1921

WWI: Rockefeller
scientist and
Nobel laureate
Alexis Carrel

Founder's Hall completed.1906
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that reach far beyond the research lab and into
every area of human endeavor - business, philoso
phy, ethics, the arts. For scientists working in our
own so-called postgenomic era, the span of less
than 60 years siI_,1ce The Rockefeller University's
discovery is uncanny.
Visit any of The Rockefeller University's 75
major laboratories today and you will find scientists
writing new chapters in the textbook of DNA
history. Among them: Robert G. Roeder, Ph.D., the
Arnold and Mabel Beckman Professor and head of
the Laboratory of Biochemistry and Molecular
Biology, who stands at the center of research to reveal
the basic principles of mammalian transcription.
Transcription is the process by which the
identical sets of genetic instructions contained in
each of the body's 200 distinct types of cells are

Oswald Avery. Colin Macleod.
and Maclyn McCarty
discover DNA carries
hereditary information.
1944

Charles Lindbergh
and Alexis Carrel
appear on 'lime"
magazine cover
with their perfusion
apparatus. which
keeps organs alive
in the lab for two
���::::-·� weeks. 1938

•�==========$-1

1930

1935

WWII: Rebecca C. Lancefield's
expertise in identifying bacterial
types assists war effort early
, 1940s

1940

1945

Karl Landsteiner receives 1930
Nobel Prize for classifying blood
groups; he later discovers
Rh blood factor

Wendell Stanley
shows a virus can
be crystallized.
1935; he shares
1946 Nobel Prize
with John Northrop

Electron
microscopy reveals inner
structure of cells. 1945:
for founding the field of cell
biology.Albert Claude.
Christian de Duve. and
George E. Palade share
1974 Nobel Prize

1950

1955

Stanford Moore and
William Stein describe
the enzyme pancreatic
ribonuclease. which
breaks down RNA.
1959: for this work
they receive 1972
Nobel Prize

"Because Rockefeller
offers itsfaculty
extraordinary resources and freedom)
they are able to take scientific risks that

individualized to distinguish, for example, a skin
cell from a muscle cell. Through transcription, the
cell's machinery issues marching orders of precisely
which genes to express, or "switch on." A gene
must be "on" to generate recipes for proteins; the
particular prot eins expressed ultimately determine
the cell's function in the body.
And, because diseases such as cancer,
Alzheimer's and AIDS can arise when transcrip
tion breaks down, understanding how a gene
transcribes its insttuctions accelerates research to
create more effective medical therapies.
In 1944, The Rockefeller Universit y ushered
biology into the modern age. Today, Roeder is
one of the university's 75 scientific leaders making
the discoveries that continue to transform science.

would be unimaginable anywhere else. n
Joshua Lederberg, Ph.D.
President Emeritus
Raymond and Beverly Sackler Scholar
Nobel P rize in Physiology or Medicine, 1958

Mike Young clones

"per" gene. which

Method for
, synthesizing
' peptides and
proteins developed
byR.Bruce
Merrifield,1963;
he wins 1984
Nobel Prize

1960

1965

affects circadian
rhythms. in fruitflies.
1984

Robert Roeder identi
fies and clones first
gene-specific tran
scriptional regulatory
factor - key to how
genetic information in
DNA is converted into
protein.1988

Dendritic cell. vital white
blood cell that alerts immune
system to presence of foreign
invaders in diseases.
discovered by Zanvil Cohn
andRalph Steinman, 1973

1970

1975

Gerald Edelman awarded 1972
Nobel Prize for showing
chemical structure of antibodies

Rockefeller awards Ph.D.s
to first graduating class.
1959
Vincent Dole develops methadone for
managment of heroin addiction.1960s;
receives 1988 Lasker Award

Emil Gotschlich
receives 1978
Lasker Award for his
role in developing
vaccine against
Group C meningitis

1980

1990

1985

1

Roderick MacKinnon
reveals structure of
potassium ion channel.
shedding light on nerve
cell communication,1998

Mary Beth Hatten and
Nathaniel Heintz identify
gene involved in direct
ing nerve cells to their
destinations as brain
grows.1994

James E. Darnell Jr.
awarded 2002
Lasker Award for
Special Achievement
in Medical Science

1995

2000

2001

litia de Lange helps determine
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